168 related articles for article (PubMed ID: 38415139)
1. Development and validation of a radiomics model based on T2-weighted imaging for predicting the efficacy of high intensity focused ultrasound ablation in uterine fibroids.
Cheng Y; Yang L; Wang Y; Kuang L; Pan X; Chen L; Cao X; Xu Y
Quant Imaging Med Surg; 2024 Feb; 14(2):1803-1819. PubMed ID: 38415139
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of conventional MRI combined with radiomics in the immediate ablation rate of HIFU treatment for uterine fibroids.
Wei C; Li N; Shi B; Wang C; Wu Y; Lin T; Chen Y; Ge Y; Yu Y; Dong J
Int J Hyperthermia; 2022; 39(1):475-484. PubMed ID: 35271784
[TBL] [Abstract][Full Text] [Related]
3. Prediction of non-perfusion volume ratio for uterine fibroids treated with ultrasound-guided high-intensity focused ultrasound based on MRI radiomics combined with clinical parameters.
Zhou Y; Zhang J; Li C; Chen J; Lv F; Deng Y; Chen S; Du Y; Li F
Biomed Eng Online; 2023 Dec; 22(1):123. PubMed ID: 38093245
[TBL] [Abstract][Full Text] [Related]
4. A Prediction of NPVR ≥ 80% of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Uterine Fibroids.
Yang MJ; Yu RQ; Chen WZ; Chen JY; Wang ZB
Front Surg; 2021; 8():663128. PubMed ID: 34150838
[No Abstract] [Full Text] [Related]
5. An interpretable MRI-based radiomics model predicting the prognosis of high-intensity focused ultrasound ablation of uterine fibroids.
Li C; He Z; Lv F; Liu Y; Hu Y; Zhang J; Liu H; Ma S; Xiao Z
Insights Imaging; 2023 Jul; 14(1):129. PubMed ID: 37466728
[TBL] [Abstract][Full Text] [Related]
6. The Predictive Effect of Quantitative Analysis of Signal Intensity Heterogeneity on T2-Weighted MR Images for High-intensity Focused Ultrasound Treatment of Uterine Fibroids.
Wang L; Liu Y; Lin J; Pan Y; Liu Y; Lv F
Acad Radiol; 2024 May; ():. PubMed ID: 38704283
[TBL] [Abstract][Full Text] [Related]
7. Achieving NPVR ≥ 80% as technical success of high-intensity focused ultrasound ablation for uterine fibroids: a cohort study.
Li S; Yang M; Yu J; Ma W; Deng Y; Hu L; Chen JY
BMC Womens Health; 2024 May; 24(1):294. PubMed ID: 38762488
[TBL] [Abstract][Full Text] [Related]
8. Prediction using T2-weighted magnetic resonance imaging-based radiomics of residual uterine myoma regrowth after high-intensity focused ultrasound ablation.
Zhou Y; Zhang J; Chen J; Yang C; Gong C; Li C; Li F
Ultrasound Obstet Gynecol; 2022 Nov; 60(5):681-692. PubMed ID: 36054291
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids.
Wei C; Fang X; Wang CB; Chen Y; Xu X; Dong JN
Abdom Radiol (NY); 2018 Aug; 43(8):2169-2175. PubMed ID: 29204677
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-guided HIFU for uterine fibroids of hyperintense on T2-weighted MR imaging with or without GnRH-analogue-pretreated: A propensity score matched cohort study.
Jiang L; Yu JW; Yang MJ; Zhong Q; Chen JY
Front Surg; 2022; 9():975839. PubMed ID: 35990089
[TBL] [Abstract][Full Text] [Related]
11. Nonenhanced MRI-based radiomics model for preoperative prediction of nonperfused volume ratio for high-intensity focused ultrasound ablation of uterine leiomyomas.
Zheng Y; Chen L; Liu M; Wu J; Yu R; Lv F
Int J Hyperthermia; 2021; 38(1):1349-1358. PubMed ID: 34486913
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance-guided high-intensity focused ultrasound of uterine fibroids: whole-tumor quantitative perfusion for prediction of immediate ablation response.
Li C; Jin C; Liang T; Li X; Wang R; Zhang Y; Yang J
Acta Radiol; 2020 Aug; 61(8):1125-1133. PubMed ID: 31779469
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcome and risk factors of reintervention after high intensity focused ultrasound ablation for uterine fibroids: a systematic review and meta-analysis.
Dou Y; Zhang L; Liu Y; He M; Wang Y; Wang Z
Int J Hyperthermia; 2024; 41(1):2299479. PubMed ID: 38164630
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of physician experience in achieving non-perfused volume ratio of high-intensity focused ultrasound ablation for uterine fibroids: a multicentre study.
Gong X; Zhang X; Liu D; Yang C; Zhang R; Xiao Z; Chen W; Chen J
J Int Med Res; 2022 May; 50(5):3000605221102087. PubMed ID: 35634930
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation in Women With Multiple Uterine Fibroids: An Exploratory Study.
Shi L; Zhang R; Tao S; Yuan X; Zhang J; Wang B; Xiang M; Ren Z; Cai H; Fu C
Ultrasound Med Biol; 2023 Nov; 49(11):2378-2387. PubMed ID: 37596155
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Dose and Effectiveness of a Single-Session Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids With Different Sizes.
Yang MJ; Yu RQ; Chen JY; Wang ZB
Front Oncol; 2021; 11():725193. PubMed ID: 34993130
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting effects of ultrasound guided high intensity focused ultrasound for single uterine fibroids: a retrospective analysis.
Fan HJ; Cun JP; Zhao W; Huang JQ; Yi GF; Yao RH; Gao BL; Li XH
Int J Hyperthermia; 2018; 35(1):534-540. PubMed ID: 30428735
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of apparent diffusion coefficient in predicting the technical outcome of MR-guided high-intensity focused ultrasound treatment of uterine fibroids - a comparison with the Funaki classification.
Sainio T; Saunavaara J; Komar G; Mattila S; Otonkoski S; Joronen K; Perheentupa A; Blanco Sequeiros R
Int J Hyperthermia; 2021; 38(1):85-94. PubMed ID: 33506700
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Clinical Outcome for High-Intensity Focused Ultrasound Ablation of Uterine Leiomyomas Using Multiparametric MRI Radiomics-Based Machine Leaning Model.
Zheng Y; Chen L; Liu M; Wu J; Yu R; Lv F
Front Oncol; 2021; 11():618604. PubMed ID: 34567999
[TBL] [Abstract][Full Text] [Related]
20. Physician Experience in Technical Success of Achieving NPVR ≥ 80% of High-Intensity Focused Ultrasound Ablation for Uterine Fibroids: A Multicenter Study.
Gong X; Zhang X; Liu D; Yang C; Zhang R; Xiao Z; Chen W; Chen J
Front Med Technol; 2021; 3():790956. PubMed ID: 35345412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
